UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Introduction to a review series on megakaryopoiesis and platelet production

Blood, 2022-06, Vol.139 (22), p.3227-3227

2022

Volltextzugriff (PDF)

Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts

Blood, 2011-07, Vol.118 (2), p.282-288

2011

Volltextzugriff (PDF)

A 1-year randomized controlled trial of deferasirox vs deferoxamine for myocardial iron removal in β-thalassemia major (CORDELIA)

Blood, 2014-03, Vol.123 (10), p.1447-1454

2014

Volltextzugriff (PDF)

Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

Blood, 2011-05, Vol.117 (18), p.4691-4695

2011

Volltextzugriff (PDF)

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

Blood, 2013-05, Vol.121 (22), p.4439-4442

2013

Volltextzugriff (PDF)

Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort

Blood, 2012-03, Vol.119 (12), p.2746-2753

2012

Volltextzugriff (PDF)

Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report

Blood, 2011-10, Vol.118 (14), p.3794-3802

2011

Volltextzugriff (PDF)

Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assay

Blood, 2014-02, Vol.123 (8), p.e11-e22

2014

Volltextzugriff (PDF)

The principal results of the International Immune Tolerance Study: a randomized dose comparison

Blood, 2012-02, Vol.119 (6), p.1335-1344

2012

Volltextzugriff (PDF)

Preterm neonates benefit from low prophylactic platelet transfusion threshold despite varying risk of bleeding or death

Blood, 2019-12, Vol.134 (26), p.2354-2360

2019

Volltextzugriff (PDF)

Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups

Blood, 2010-05, Vol.115 (18), p.3827-3834

2010

Volltextzugriff (PDF)

VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease

Blood, 2013-03, Vol.121 (12), p.2336-2339

2013

Volltextzugriff (PDF)

The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia

Blood, 2008-02, Vol.111 (4), p.1820-1826

2008

Volltextzugriff (PDF)

Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS)

Blood, 2013-05, Vol.121 (22), p.4457-4462

2013

Volltextzugriff (PDF)

Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project

Blood, 2013-07, Vol.122 (4), p.590-597

2013

Volltextzugriff (PDF)

A GWAS sequence variant for platelet volume marks an alternative DNM3 promoter in megakaryocytes near a MEIS1 binding site

Blood, 2012-12, Vol.120 (24), p.4859-4868

2012

Volltextzugriff (PDF)

All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)

Blood, 2012-08, Vol.120 (8), p.1570-1580

2012

Volltextzugriff (PDF)

iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL

Blood, 2018-06, Vol.131 (25), p.2745-2760

2018

Volltextzugriff (PDF)

Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?

Blood, 2018-11, Vol.132 (18), p.1871-1878

2018

Volltextzugriff (PDF)

Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma

Blood, 2021-02, Vol.137 (5), p.637-645

2021

Volltextzugriff (PDF)

Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables

Blood, 2019-07, Vol.134 (2), p.111-122

2019

Volltextzugriff (PDF)

1 – 25 von 13.310

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBlood

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13.310)
Mit Volltextzugriff
(13.250)

Publikationsform

Artikel
(13.308)
Reviews
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Hematology
(3.654)
Life Sciences & Biomedicine
(3.622)
Science & Technology
(3.622)
Humans
(3.265)
Biological And Medical Sciences
(2.412)
Medical Sciences
(1.990)
Female
(1.338)
Male
(1.328)
Hematologic And Hematopoietic Diseases
(1.311)
Animals
(1.195)
Adult
(992)
Mice
(899)
Middle Aged
(867)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(719)
Aged
(628)
Adolescent
(472)
Fundamental And Applied Biological Sciences. Psychology
(461)
Child
(412)
Treatment Outcome
(357)
Cells, Cultured
(341)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Free E-Journals
(13.310)
NUS Single-Journal Subscriptions
(13.310)
MEDLINE
(3.823)

Zeitschrift / Serie

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Introduction to a review series on megakaryopoiesis and platelet production

Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A

Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts

A 1-year randomized controlled trial of deferasirox vs deferoxamine for myocardial iron removal in β-thalassemia major (CORDELIA)

Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort

Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report

Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assay

High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study

The principal results of the International Immune Tolerance Study: a randomized dose comparison

Preterm neonates benefit from low prophylactic platelet transfusion threshold despite varying risk of bleeding or death

Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups

Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation

VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease

inv(16)/t(16;16) acute myeloid leukemia with non–type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations

The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia

Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS)

Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project

A GWAS sequence variant for platelet volume marks an alternative DNM3 promoter in megakaryocytes near a MEIS1 binding site

All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)

iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL

Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?

Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma

Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables

Aktive Filter

Suchergebnisse filtern